A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

Comments (0)

Related news

AMD stock jumps 7% on earnings as data center revenue nearly doubles

Eaton's strong quarter should mark a bottom for shares of the AI buildout winner

AMD has been crushed into earnings. Here’s one way to trade it

Fannie Mae, Freddie Mac rally as Ackman presses for conservatorship exit

Election Day: Here is the No. 1 issue we're watching as a signal for stocks

Options traders are betting heavily on these stocks ahead of election results

We're trimming some more off a stock that's enjoying nice post-earnings gains

Bill Ackman warns of 'casino' stock market as speculative trading grows

Midterm Elections: Americans Have Wagered $1.9 Billion on Prediction Markets on U.S. Races — With Democrats Favored to Win House and Senate

Car finance: Barclays becomes first big lender to offer payouts for mis-selling of loans

Santoli: AI bull market almost surely needs tech stocks to recover to keep advancing

Midterm elections could jolt stocks if Democrats sweep Congress

Oil prices climb after U.S. strikes Iran's Qeshm Island

Apple and Palantir shares slide in premarket trading following post-bell earnings

Australia hikes rates to 18-year high to fight inflation

RBA interest rates: Reserve Bank hikes cash rate for fifth time this year in blow to mortgage holders

Apple's quarter is not perfect. But with enough to like, we raised our price target

I bonds now pay 5.51% — but there are trade-offs. What to know before buying

Intel foundry push faces critical test after stock's 45% plunge in October

2 of our banks are at the heart of this week's biggest tech deals

Prediction market traders now see nearly 75% chance of Democrats winning the Senate

Apple reports after the bell. Options traders expect a big move

Oil price falls amid hope of a breakthrough to end Iran war

We're trimming a rallying industrial stock, looking for its next catalyst post-spinoff